Investigational Drug Information for Oxamic Acid
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
What is the development status for investigational drug Oxamic Acid?
Oxamic Acid is an investigational drug.
There have been 139 clinical trials for Oxamic Acid.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 12th 2013.
The most common disease conditions in clinical trials are Lymphoma, Leukemia, and Lymphoma, Non-Hodgkin. The leading clinical trial sponsors are National Cancer Institute (NCI), Merck Sharp & Dohme Corp., and M.D. Anderson Cancer Center.
Summary for Oxamic Acid
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,010 |
| WIPO Patent Applications | 3,133 |
| Japanese Patent Applications | 792 |
| Clinical Trial Progress | Phase 3 (2013-02-12) |
| Vendors | 77 |
Recent Clinical Trials for Oxamic Acid
| Title | Sponsor | Phase |
|---|---|---|
| Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer | Merck Sharp & Dohme Corp. | Phase 2 |
| Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer | University of California, San Francisco | Phase 2 |
| Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma | National Cancer Institute (NCI) | Phase 2 |
Clinical Trial Summary for Oxamic Acid
Top disease conditions for Oxamic Acid
Top clinical trial sponsors for Oxamic Acid
US Patents for Oxamic Acid
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
